showed that FBXW7 inhibits malignant proliferation and migration of cholangiocarcinoma cells and enhances their sensitivity to cisplatin chemotherapy, by modulating NOTCH1 and MCL1 expression. The gene discussed is MCL1; the disease is cholangiocarcinoma.